Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|April 28, 2005
Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapiesM Folini, N Zaffaroni
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Targeting human telomerase by antisense oligonucleotides and ribozymesM Folini, M Pennati, N Zaffaroni
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
Hyperthermia and hypoxia: new developments in anticancer chemotherapyN Zaffaroni, G Fiorentini, U De Giorgi
Mini Reviews in Medicinal Chemistry|February 7, 2003
Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymesN Zaffaroni, R Villa, M Pennati, et al.
Stem Cells (Dayton, Ohio)|November 1, 1993
In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancerR Silvestrini, N Zaffaroni, L Orlandi, et al.
British Journal of Cancer|December 1, 1996
Effect of melphalan and hyperthermia on p34cdc2 kinase activity in human melanoma cellsL Orlandi, N Zaffaroni, A Bearzatto, et al.
Current Medicinal Chemistry|February 26, 2013
Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drugG L Beretta, L Gatti, P Perego, et al.
Current Medicinal Chemistry|December 30, 2011
Targeting DNA topoisomerase I with non-camptothecin poisonsG L Beretta, V Zuco, P Perego, et al.
Pageof 9